Once R&D approval has been issued NHS GG&C has responsibility for:
Multi-site Studies Where a research study is being extended to sites outwith GG&C to other NHS organisations, R&D will generate multi-site agreements which set out the responsibility of each party. R&D regularly organise international trials which have global sites round the world, e.g. U.S.A, Australia, France and Japan.
Monitoring R&D has a responsibility to monitor research studies conducted on its premises under ICH-GCP, the Scottish Executive Research Governance Framework for Health and Community Care (2nd edition February 2006) and the Medicines for Human Use (Clinical Trials) Regulations, 2004 No. 1031 (as amended).